# OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

> **NCT03180307** · PHASE3 · COMPLETED · sponsor: **On Target Laboratories, LLC** · enrollment: 140 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** OTL38
- **DEVICE:** near infrared camera imaging system
- **PROCEDURE:** laparotomy

## Key facts

- **NCT ID:** NCT03180307
- **Lead sponsor:** On Target Laboratories, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-26
- **Primary completion:** 2020-04-16
- **Final completion:** 2020-10-16
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2022-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03180307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03180307, "OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03180307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*